RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Novartis AG

A collection of news and information related to Novartis AG published by this site and its partners.

Top Novartis AG Articles see all

Displaying items 1-5
  • Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.
  • Good news hard to find without reading glasses

    Good news hard to find without reading glasses
    Some days when the misery, mayhem and free-floating lunacy of the world are too much to absorb, when any effort to absorb it all feels pointless to the point of masochistic, I go in search of a little good news. But before I can read the news, I have to...

    The 10 L.A. startups that raised the most money this spring

    The 10 L.A. startups that raised the most money this spring
    Led by Swagbucks’ $60 million round of fund-raising, 35 Los Angeles County startups raised more than $330 million from April through June in what was a booming second quarter for startup investment nationwide. The money is flowing to fewer firms,...

    The meningitis outbreak we weren't ready for

    The meningitis outbreak we weren't ready for
    During the last two years, there have been a couple of outbreaks and sporadic cases of bacterial meningitis that federal health agencies failed to address with sufficient aggressiveness. It could have been much worse, and the experience should serve as...

    Pfizer walks away from AstraZeneca takeover attempt

    Pfizer walks away from AstraZeneca takeover attempt
    Pfizer Inc. said Monday that it had abandoned its current attempt to buy AstraZeneca PLC for nearly $118 billion — a deal watched warily by Maryland officials — as a deadline approached without a last-minute change of heart by the British...